Biotech News
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
investors.hyperfine.io2026-05-06 15:08 EST
Hyperfine Delivers Quarterly Record Revenue of Approximately $5.3 Million in Q4 2025, Representing Transformative Growth of 54% Compared to Prior Quarter; Exiting 2025 with Approximately $35 Million of Cash and Cash Equivalents. GUILFORD, Conn. --(BUSINESS WIRE)--Jan. 12, 2026-- Hyperfine, Inc.